Jan 6, 2025 8:15 am EST Profound Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Dec 10, 2024 9:55 am EST Profound Medical Announces Closing of US$40.25 Million Underwritten Public Offering of Common Shares
Dec 6, 2024 9:04 am EST Profound Medical Announces Pricing of US$35 Million Underwritten Public Offering of Common Shares
Dec 2, 2024 7:30 am EST Profound Medical and Siemens Healthineers to Offer a Complete Solution for MRI-guided Prostate Therapy
Nov 4, 2024 6:55 am EST Profound Medical Announces TULSA Reimbursement Raised to Urology APC Level 7 Under CMS Outpatient Prospective Payment System (OPPS) Final Rule for CY2025
Oct 17, 2024 4:30 pm EDT Profound Medical to Release Third Quarter 2024 Financial Results on November 7 – Conference Call to Follow